BioCentury
ARTICLE | Financial News

Catalent sets terms for NYSE IPO

July 18, 2014 11:29 PM UTC

Catalent Inc. (Somerset, N.J.) said it plans to sell 42.5 million shares at $19-$22 in an IPO on the NYSE. At the $20.50 midpoint, the company would raise $871.3 million and be valued at $2.4 billion. Catalent filed to raise up to $100 million in the offering in January. Morgan Stanley; JPMorgan; BofA Merrill Lynch; Goldman Sachs; Jefferies; Deutsche Bank; Blackstone Capital Markets; Piper Jaffray; Raymond James; Wells Fargo Securities; William Blair; and Evercore are underwriters. ...